<DOC>
	<DOC>NCT00136773</DOC>
	<brief_summary>Type 2 diabetes mellitus is usually associated with high blood pressure, which is a risk factor for kidney disease. Aggressive blood pressure reduction is an important strategy to protect the kidney and reduce urinary protein which develops with kidney disease. This study will evaluate the effects of amlodipine/benazepril in reducing blood pressure and urinary protein in hypertensive subjects with type 2 diabetes mellitus.</brief_summary>
	<brief_title>Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Mild to moderate hypertension Type 2 diabetes mellitus Presence of protein in the urine (albuminuria) Kidney disease not caused by diabetes or hypertension Renal artery stenosis Myocardial infarction or stroke within the last 6 months Type 1 diabetes mellitus Pregnant or lactating females Cancer within the last 5 years</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Albuminuria</keyword>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Hypertension</keyword>
</DOC>